Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Geneoscopy, Inc.

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of a Second Patent Asserted by Exact Sciences
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
From Geneoscopy, Inc.
Via Business Wire
Tickers BIO
Geneoscopy’s Dr. Erica Barnell to Present at Women @ Work Summit and American Gastroenterological Association Workshop
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Receives New York State Department of Health Permit, Expanding Ability to Provide Laboratory Services Nationwide
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy to Present at Gastroenterology and Cancer Surveillance Conferences, Highlighting Advancements in Colorectal Cancer Screening and Early Detection
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy’s CEO Andrew Barnell to Present at Upcoming Investor Conferences
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy’s Novel Stool-Based RNA Platform Shows High Accuracy in Monitoring Crohn’s Disease
From Geneoscopy, Inc.
Via Business Wire
U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of ‘781 Patent Owned by Exact Sciences
From Geneoscopy, Inc.
Via Business Wire
Peer-Reviewed Study Confirms Reliability of ColoSense, Geneoscopy’s Noninvasive Multi-target Stool RNA Colorectal Cancer Screening Test
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Files Counterclaims Against Exact Sciences
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Advances Mission to Transform Gastrointestinal Health at Digestive Disease Week 2024
From Geneoscopy, Inc.
Via Business Wire
Court Dismisses Exact Sciences’ ‘781 Patent Infringement Claim Against Geneoscopy
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Expands Leadership Team to Support ColoSense™ Rollout and Advance Precision IBD Solutions
From Geneoscopy, Inc.
Via Business Wire
FDA Approves ColoSense™ – Geneoscopy's Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Forms Scientific Advisory Board to Support Advancement of Precision Immunology Diagnostics for Inflammatory Bowel Disease (IBD)
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy Files Inter Partes Review Petition Challenging Exact Sciences’ Patent
From Geneoscopy, Inc.
Via Business Wire
Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease
From Geneoscopy, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.